Treatment strategy targeting 5-HT6R in an innovative animal model of Schizophrenia - Archive ouverte HAL
Poster De Conférence Année : 2024

Treatment strategy targeting 5-HT6R in an innovative animal model of Schizophrenia

Résumé

Schizophrenia (SCZ) is a frequent psychosis related to combination between genetic and environmental factors. To advance current treatments, it is important to improve animal models by considering its multifactorial etiology. Our study aimed to characterize an innovative 2-hit mouse model combining the deletion of serine racemase (genetic factor) associated with a maternal separation for 24h at post-natal day 9 (early stressing environmental factor), which both have been previously suggested to possibly drive SCZ-like symptoms. The face facility of this 2-hit model was assessed through behavioral experiments. Hence, male mice displayed an increase in locomotor activity possibly reflecting positive-like symptoms, working memory impairments illustrating cognitive deficits and recognition memory alterations that could underlie neophobia.
The model was then used to investigate therapeutic interest of the 5-HT6R antagonist SB-271046 since beneficial effects of 5-HT6R blockade on memory and anxiety-like effects has been reported. Interestingly, sub-chronic (2 weeks) treatment with SB-271046 at 10mg/kg/day prevented the cognitive deficits, but not the hyperlocomotion symptom. Taken together, our results show that 1) this new multifactorial model displays an interesting phenotype for modelling SCZ and 2) the efficacy of the 5- HT6R antagonism strategy is limited and requires combination with antipsychotic drugs or physical activity to better counteract the deficits observed in our model that is under investigation.
Fichier principal
Vignette du fichier
LAHOGUE_FENS_poster.pdf (699.03 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Licence

Dates et versions

hal-04634813 , version 1 (15-07-2024)

Licence

Identifiants

  • HAL Id : hal-04634813 , version 1

Citer

Caroline Lahogue, Michel Boulouard, François Menager, Thomas Freret, Jean-Marie Billard, et al.. Treatment strategy targeting 5-HT6R in an innovative animal model of Schizophrenia. FENS 2024, Jun 2024, Vienne, Austria. ⟨hal-04634813⟩
40 Consultations
22 Téléchargements

Partager

More